T. Rowe Price reports 3.0% stake in Bruker
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G/A reporting its beneficial ownership of 4,594,398 shares of Bruker Corp common stock, representing 3.0% of the class as of 12/31/2025.
Rhea-AI Filing Summary
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G/A reporting its beneficial ownership of 4,594,398 shares of Bruker Corp common stock, representing 3.0% of the class as of 12/31/2025. The firm has sole voting power over 4,584,656 shares and sole dispositive power over 4,594,398 shares, with no shared voting or dispositive power. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Bruker. The filer also affirms that this should not be construed as an admission of beneficial ownership, which is expressly denied.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Bruker Corp (BRKR) does T. Rowe Price report in this filing?
Why is Bruker Corp’s Schedule 13G/A with T. Rowe Price significant for investors?
Does T. Rowe Price intend to influence control of Bruker Corp (BRKR)?
What does the 5 percent or less disclosure mean in this Bruker 13G/A?
Who signed the Bruker Corp (BRKR) Schedule 13G/A on behalf of T. Rowe Price?
AI-generated analysis. How Rhea-AI works. Not financial advice.